NanoPhoria Revenue and Competitors
Estimated Revenue & Valuation
- NanoPhoria's estimated annual revenue is currently $1.1M per year.
- NanoPhoria's estimated revenue per employee is $155,000
Employee Data
- NanoPhoria has 7 Employees.
- NanoPhoria grew their employee count by 0% last year.
NanoPhoria's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder & CEO | Reveal Email/Phone |
2 | Project Manager | Reveal Email/Phone |
NanoPhoria Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.1M | 7 | 0% | N/A | N/A |
#2 | $1.9M | 12 | 9% | N/A | N/A |
What Is NanoPhoria?
NanoPhoria is a preclinical stage biotech company pioneering inhalable cardiovascular treatments via non-viral nano-delivery of biologics.\n\nThe Company is devoted to the clinical development of an innovative proprietary platform for the tissue-directed delivery of therapeutic peptides and RNAs. The core vehicle is an inorganic calcium-phosphate nanoparticle\nwhich represents a versatile, biomimetic nano-carrier that can be loaded or surface decorated with biologics and can be formulated for inhalation or for other administration routes.\n\nNanoPhoria’s lead product, NP-MP1 is an inhalable nano-in-micro formulation, delivering a proprietary peptide, first-in-class calcium channel modulator, for the treatment of Heart Failure with reduced Ejection Fraction, a chronic syndrome affecting the lives of millions worldwide.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Milan
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 7 | 75% | N/A |
#2 | $0.8M | 8 | 0% | N/A |
#3 | $0.6M | 8 | -47% | N/A |
#4 | $0.6M | 8 | 0% | N/A |
#5 | $0.9M | 8 | -11% | N/A |